Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days £260.00 £353.00 Friday, 10th May 2024 HCM.L stock ended at £352.00. This is 13.55% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 3.22% from a day low at £342.00 to a day high of £353.00.
90 days £202.50 £353.00
52 weeks £173.60 £353.00

Historical Hutchison China Meditech Ltd ADR (Sponsored) prices

Date Open High Low Close Volume
Dec 14, 2023 £311.50 £319.50 £302.00 £305.50 67 920
Dec 13, 2023 £305.60 £308.00 £299.00 £301.50 24 324
Dec 12, 2023 £282.00 £308.00 £282.00 £303.50 162 781
Dec 11, 2023 £290.00 £299.50 £281.80 £293.00 109 034
Dec 08, 2023 £292.30 £303.50 £292.30 £294.50 38 401
Dec 07, 2023 £297.58 £300.50 £290.50 £300.00 69 687
Dec 06, 2023 £278.30 £287.00 £277.50 £285.00 42 184
Dec 05, 2023 £278.85 £298.00 £277.85 £280.00 33 491
Dec 04, 2023 £287.44 £294.10 £275.50 £279.00 128 934
Dec 01, 2023 £300.00 £303.00 £284.50 £290.00 48 071
Nov 30, 2023 £286.00 £308.00 £286.00 £305.00 281 962
Nov 29, 2023 £292.00 £299.49 £289.50 £297.00 73 120
Nov 28, 2023 £300.50 £312.00 £300.50 £305.00 137 308
Nov 27, 2023 £300.00 £300.00 £300.00 £300.00 0
Nov 24, 2023 £305.00 £309.00 £290.52 £300.00 626 190
Nov 23, 2023 £299.00 £305.00 £299.00 £300.00 158 061
Nov 22, 2023 £285.50 £293.00 £282.50 £288.50 41 291
Nov 21, 2023 £287.60 £296.00 £287.41 £287.50 9 227
Nov 20, 2023 £292.20 £300.00 £289.40 £298.00 68 573
Nov 17, 2023 £273.00 £302.00 £272.87 £296.50 256 426
Nov 16, 2023 £303.85 £303.85 £280.00 £282.00 73 756
Nov 15, 2023 £310.00 £310.00 £290.50 £305.00 58 695
Nov 14, 2023 £312.50 £312.50 £298.52 £307.00 182 780
Nov 13, 2023 £293.50 £311.10 £289.00 £303.50 226 653
Nov 10, 2023 £290.00 £310.50 £285.10 £309.50 102 842
Click to get the best stock tips daily for free!

About Hutchison China Meditech Ltd ADR (Sponsored)

Hutchison China Meditech Ltd ADR (Sponsored) HUTCHMED (China) Limited discovers, develops, and commercializes targeted therapeutics and immunotherapies for cancer and immunological diseases in HongKong and internationally. It operates in Oncology/Immunology and Other Ventures segments. The company develops Savolitinib, an inhibitor for non-small cell lung cancer (NSCLC), papillary and renal cell carcinoma, colorectal cancer (CRC), and gastric cancer (GC); and Fruquintinib, an inhibitor for ... HCM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT